NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

Entero Healthcare Solutions ‘s Q3 2024-25 Latest News: Profit Grows by 321.92% YoY

[fetch_key]

Highlights

🔹 The presented financial data is Consolidated to provide a comprehensive overview of the company performance.
🔹 Sales over the Year and quarter: The company experienced a substantial growth of 36.91 % in the past year, substantial increase in net sales/revenue by 4.48 %.
🔹 Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 319.12 %. Marginal decrease of -33.52% in other income during this quarter.
🔹 Profit over the Year and quarter: Significant improvement in profitability for Entero Healthcare Solutions Limited. Notable increase of 321.83 % in net profit Year to Year, Entero Healthcare Solutions Limited’s profitability increased by 13.12 % in this quarter.
🔹 EPS over the Year and quarter: EPS increased by 206.28 % Year to Year. EPS increased by 7.73 % in previous quarter. Positive impact on shareholders.

In our extensive review of Entero Healthcare Solutions Limited, we incorporate a thorough examination of the company’s market trends, investment risks, and growth opportunities. The analysis highlights how external economic factors, regulatory changes, and technological advancements could impact the company’s future performance. Additionally, it includes a detailed look at the company’s dividend policy and its commitment to returning value to shareholders. This holistic approach to understanding Entero Healthcare Solutions Limited’s financial and strategic outlook is designed to assist investors in crafting a robust investment portfolio that aligns with their financial goals and risk tolerance.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 992.633 Cr Rs. 1300.692 Cr Rs. 1358.996 Cr + 4.48 % + 36.91 %
Expenses Rs. 964.04 Cr Rs. 1258.24 Cr Rs. 1308.99 Cr + 4.03 % + 35.78 %
Operating Profit Rs. 28.59 Cr Rs. 42.45 Cr Rs. 50.01 Cr + 17.81 % + 74.92 %
OPM % 2.88 % 3.26 % 3.68 % + 0.42 % + 0.8 %
Other Income Rs. 1.789 Cr Rs. 11.279 Cr Rs. 7.498 Cr -33.52 % + 319.12 %
Interest Rs. 16.07 Cr Rs. 11.46 Cr Rs. 9.97 Cr -13 % -37.96 %
Depreciation Rs. 5.99 Cr Rs. 7.49 Cr Rs. 8.1 Cr + 8.14 % + 35.23 %
Profit before tax Rs. 8.32 Cr Rs. 34.78 Cr Rs. 39.44 Cr + 13.4 % + 374.04 %
Tax % 16.12 % 25.14 % 25.33 % + 0.19 % + 9.21 %
Net Profit Rs. 6.98 Cr Rs. 26.03 Cr Rs. 29.45 Cr + 13.14 % + 321.92 %
EPS in Rs Rs. 1.91 Rs. 5.42 Rs. 5.84 + 7.75 % + 205.76 %


Today, we’re looking at Entero Healthcare Solutions Limited’s financial performance for the Q3(Dec 2024-25).Starting with the top line, the company reported a robust year-over-year sales growth of 36.91 %. However, it did see a marginal increase of 4.48 % from the previous quarter. Expenses ticked up slightly by 4.03 % quarter-on-quarter, aligning with the annual rise of 35.78 %. Operating profit, while up 74.92 % compared to last year, faced a quarter-on-quarter increase of 17.81 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 0.8 %, but an expansion of 0.42 % sequentially. Other income fell by -33.52 % compared to the last quarter, despite an annual growth of 319.12 %. Interest expenses dropped significantly by -13 % from the previous quarter, yet the year-over-year decrease remains at a moderate -37.96 %. Depreciation costs climbed by 8.14 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 35.23 %. Profit before tax grew annually by 374.04 % but saw an increase from the preceding quarter by 13.4 %.
Tax expenses as a percentage of profits increased slightly by 9.21 % compared to last year, with a more notable quarter-on-quarter increase of 0.19 %. Net profit rose by 321.92 % year-on-year but experienced a 13.14 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 205.76 % but a quarterly rise of 7.75 %. In summary, Entero Healthcare Solutions Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

Metrics Previous Year Previous Quarter Current Quarter Quarter to Quarter Difference Year to Year Difference
Sales Rs. 992.633 Cr Rs. 1300.692 Cr Rs. 1358.996 Cr + 4.48 % + 36.91 %
Expenses Rs. 964.04 Cr Rs. 1258.24 Cr Rs. 1308.99 Cr + 4.03 % + 35.78 %
Operating Profit Rs. 28.59 Cr Rs. 42.45 Cr Rs. 50.01 Cr + 17.81 % + 74.92 %
Net Profit Rs. 6.98 Cr Rs. 26.03 Cr Rs. 29.45 Cr + 13.14 % + 321.92 %
EPS in Rs Rs. 1.91 Rs. 5.42 Rs. 5.84 + 7.75 % + 205.76 %


In reviewing Entero Healthcare Solutions Limited’s 2024-25(Q3) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 36.91 % year-on-year growth, however, there was a minor increase of 4.48 % from the previous quarter. Expenses rose by 35.78 % compared to the previous year, with a 4.03 % increase quarter-on-quarter. Operating Profit surged by 74.92 % annually, and saw a 17.81 % increase from the last quarter.
Net Profit showed yearly increase of 321.92 %, and experienced a 13.14 % increase from the previous quarter. Earnings Per Share (EPS) rose by 205.76 % annually, however rose by 7.75 % compared to the last quarter. In essence, while Entero Healthcare Solutions Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.

Join our telegram for more updates

Stay Updated with Our YouTube Videos

Related Post